Article ID Journal Published Year Pages File Type
10754931 Biochemical and Biophysical Research Communications 2014 6 Pages PDF
Abstract
Taken together, anethole demonstrated to act as the CXCR4 antagonist and as the PTEN activator which resulted to PI3K/AKT-mediated inhibition of the metastatic prostate cancer progressions.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Preview
CXCR4 and PTEN are involved in the anti-metastatic regulation of anethole in DU145 prostate cancer cells
Authors
, , , ,